miR-429 represses cell proliferation and induces apoptosis in HBV-related HCC

Biomedicine and Pharmacotherapy

Volumn 68, Issue 8, 2014, Pages 943-949

  Gao, Huijie ^a   Liu, Chao ^a  

^a JINING MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus (HBV); Hepatocellular carcinoma (HCC); MicroRNAs; MiR 429; NOTCH1

Indexed keywords

MICRORNA; MIRN429 MICRORNA, HUMAN;

APOPTOSIS; BIOSYNTHESIS; CELL PROLIFERATION; HEPATITIS B; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; HEP G2 CELLS; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MICRORNAS;

EID: 84916240042     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.09.005     Document Type: Article

References (28)

1. Song I.H., Kim K.S. Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol 2009, 15(Suppl.6):S50-S59.
2. Bouchard M.J., Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett 2011, 305:123-143.
3. Yang H.I., Yeh S.H., Chen P.J., Iloeje U.H., Jen C.L., Su J., et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008, 100:1134-1143.
4. Chou Y.C., Yu M.W., Wu C.F., Yang S.Y., Lin C.L., Liu C.J., et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 2008, 57:91-97.
5. Kim D.W., Lee S.A., Hwang E.S., Kook Y.H., Kim B.J. Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma. PLoS One 2012, 7:e47372.
6. Hagen T.M., Huang S., Curnutte J., Fowler P., Martinez V., Wehr C.M., et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci U S A 1994, 91:12808-12812.
7. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009, 49:1098-1112.
8. Nathans R., Chu C.Y., Serquina A.K., Lu C.C., Cao H., Rana T.M. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 2009, 34:696-709.
9. Wang C.M., Wang Y., Fan C.G., Xu F.F., Sun W.S., Liu Y.G., et al. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem Biophys Res Commun 2011, 411:586-592.
10. Wu X.J., Li Y., Liu D., Zhao L.D., Bai B., Xue M.H. miR-27a as an oncogenic microRNA of hepatitis B virus-related hepatocellular carcinoma. Asian Pac J Cancer Prev 2013, 14:885-889.
11. Wei X., Tan C., Tang C., Ren G., Xiang T., Qiu Z., et al. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal 2013, 25:1037-1043.
12. Li L.M., Hu Z.B., Zhou Z.X., Chen X., Liu F.Y., Zhang J.F., et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010, 70:9798-9807.
13. Tsai W.C., Hsu P.W., Lai T.C., Chau G.Y., Lin C.W., Chen C.M., et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009, 49:1571-1582.
14. Zhang X., Zhang E., Ma Z., Pei R., Jiang M., Schlaak J.F., et al. Modulation of hepatitis B virus replication and hepatocyte differentiation by microRNA-1. Hepatology 2011, 53:1476-1485.
15. Zou C., Li Y., Cao Y., Zhang J., Jiang J., Sheng Y., et al. Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5. BMC Cancer 2014, 14:97.
16. Guo H., Liu H., Mitchelson K., Rao H., Luo M., Xie L., et al. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology 2011, 54:808-819.
17. Jin J., Tang S., Xia L., Du R., Xie H., Song J., et al. MicroRNA-501 promotes HBV replication by targeting HBXIP. Biochem Biophys Res Commun 2013, 430:1228-1233.
18. Lee J.M., Wong C.M., Ng I.O. Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations. Cancer Res 2008, 68:5988-5996.
19. Gao P., Wong C.C., Tung E.K., Lee J.M., Wong C.M., Ng I.O. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol 2011, 54:1177-1184.
20. Zhang G.L., Li Y.X., Zheng S.Q., Liu M., Li X., Tang H. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res 2010, 88:169-175.
21. Potenza N., Papa U., Mosca N., Zerbini F., Nobile V., Russo A. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 2011, 39:5157-5163.
22. Su C., Hou Z., Zhang C., Tian Z., Zhang J. Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J 2011, 8:354.
23. Chen Y., Shen A., Rider P.J., Yu Y., Wu K., Mu Y., et al. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. Faseb J 2011, 25:4511-4521.
24. Stockhausen M.T., Kristoffersen K., Poulsen H.S. The functional role of Notch signaling in human gliomas. Neurol Oncol 2010, 12:199-211.
25. Talbot L.J., Bhattacharya S.D., Kuo P.C. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol 2012, 3:117-136.
26. Hu C., Dievart A., Lupien M., Calvo E., Tremblay G., Jolicoeur P. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol 2006, 168:973-990.
27. Liu J., Fan H., Ma Y., Liang D., Huang R., Wang J., et al. Notch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas. PLoS One 2013, 8:e56141.
28. Xu P., Qiu M., Zhang Z., Kang C., Jiang R., Jia Z., et al. The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo. J Neurooncol 2010, 97:41-51.